- call +1-201-465-4211
- email sales@mrinsights.biz
A hospital-acquired infection (HAI), also known as a nosocomial infection, is an infection that is acquired in a hospital or other health care facility.
Scope of the Report:
The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infection, awareness regarding the use of personalized medicines, and cost-effective drugs to treat hospital acquired infections are some of the factors that are driving the growth of this market.
The global Hospital Acquired Infection Control market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hospital Acquired Infection Control.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Hospital Acquired Infection Control market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hospital Acquired Infection Control market by product type and applications/end industries.
Market Segment by Companies, this report covers
Pfizer
Roche
Merck
Johnson & Johnson
Abott
Bayer
BD
Kimberly-Clark
Nordion
Cepheid
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Urinary Tract Infections
Blood Stream Infections
Surgical Site Infections
Hospital Acquired Pneumonia
Gastrointestinal Infections
Tuberculosis
Market Segment by Applications, can be divided into
Air
Water
Physical Surfaces
Skin disinfectants
Sterilization
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Hospital Acquired Infection Control Market Overview
1.1 Product Overview and Scope of Hospital Acquired Infection Control
1.2 Classification of Hospital Acquired Infection Control by Types
1.2.1 Global Hospital Acquired Infection Control Revenue Comparison by Types (2017-2023)
1.2.2 Global Hospital Acquired Infection Control Revenue Market Share by Types in 2017
1.2.3 Urinary Tract Infections
1.2.4 Blood Stream Infections
1.2.5 Surgical Site Infections
1.2.6 Hospital Acquired Pneumonia
1.2.7 Gastrointestinal Infections
1.2.8 Tuberculosis
1.3 Global Hospital Acquired Infection Control Market by Application
1.3.1 Global Hospital Acquired Infection Control Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Air
1.3.3 Water
1.3.4 Physical Surfaces
1.3.5 Skin disinfectants
1.3.6 Sterilization
1.4 Global Hospital Acquired Infection Control Market by Regions
1.4.1 Global Hospital Acquired Infection Control Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Hospital Acquired Infection Control Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hospital Acquired Infection Control Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hospital Acquired Infection Control Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Hospital Acquired Infection Control Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hospital Acquired Infection Control Status and Prospect (2013-2023)
1.5 Global Market Size of Hospital Acquired Infection Control (2013-2023)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Hospital Acquired Infection Control Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
2.2.1 Business Overview
2.2.2 Hospital Acquired Infection Control Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Hospital Acquired Infection Control Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Hospital Acquired Infection Control Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2016-2017)
2.5 Abott
2.5.1 Business Overview
2.5.2 Hospital Acquired Infection Control Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abott Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bayer
2.6.1 Business Overview
2.6.2 Hospital Acquired Infection Control Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2016-2017)
2.7 BD
2.7.1 Business Overview
2.7.2 Hospital Acquired Infection Control Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 BD Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2016-2017)
2.8 Kimberly-Clark
2.8.1 Business Overview
2.8.2 Hospital Acquired Infection Control Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Kimberly-Clark Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2016-2017)
2.9 Nordion
2.9.1 Business Overview
2.9.2 Hospital Acquired Infection Control Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Nordion Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2016-2017)
2.10 Cepheid
2.10.1 Business Overview
2.10.2 Hospital Acquired Infection Control Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cepheid Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hospital Acquired Infection Control Market Competition, by Players
3.1 Global Hospital Acquired Infection Control Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Hospital Acquired Infection Control Players Market Share
3.2.2 Top 10 Hospital Acquired Infection Control Players Market Share
3.3 Market Competition Trend
4 Global Hospital Acquired Infection Control Market Size by Regions
4.1 Global Hospital Acquired Infection Control Revenue and Market Share by Regions
4.2 North America Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
4.3 Europe Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
4.5 South America Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
5 North America Hospital Acquired Infection Control Revenue by Countries
5.1 North America Hospital Acquired Infection Control Revenue by Countries (2013-2018)
5.2 USA Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
5.3 Canada Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
5.4 Mexico Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
6 Europe Hospital Acquired Infection Control Revenue by Countries
6.1 Europe Hospital Acquired Infection Control Revenue by Countries (2013-2018)
6.2 Germany Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
6.3 UK Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
6.4 France Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
6.5 Russia Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
6.6 Italy Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Hospital Acquired Infection Control Revenue by Countries
7.1 Asia-Pacific Hospital Acquired Infection Control Revenue by Countries (2013-2018)
7.2 China Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
7.3 Japan Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
7.4 Korea Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
7.5 India Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
8 South America Hospital Acquired Infection Control Revenue by Countries
8.1 South America Hospital Acquired Infection Control Revenue by Countries (2013-2018)
8.2 Brazil Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
8.3 Argentina Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
8.4 Colombia Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Hospital Acquired Infection Control by Countries
9.1 Middle East and Africa Hospital Acquired Infection Control Revenue by Countries (2013-2018)
9.2 Saudi Arabia Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
9.3 UAE Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
9.4 Egypt Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
9.5 Nigeria Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
9.6 South Africa Hospital Acquired Infection Control Revenue and Growth Rate (2013-2018)
10 Global Hospital Acquired Infection Control Market Segment by Type
10.1 Global Hospital Acquired Infection Control Revenue and Market Share by Type (2013-2018)
10.2 Global Hospital Acquired Infection Control Market Forecast by Type (2018-2023)
10.3 Urinary Tract Infections Revenue Growth Rate (2013-2023)
10.4 Blood Stream Infections Revenue Growth Rate (2013-2023)
10.5 Surgical Site Infections Revenue Growth Rate (2013-2023)
10.6 Hospital Acquired Pneumonia Revenue Growth Rate (2013-2023)
10.7 Gastrointestinal Infections Revenue Growth Rate (2013-2023)
10.8 Tuberculosis Revenue Growth Rate (2013-2023)
11 Global Hospital Acquired Infection Control Market Segment by Application
11.1 Global Hospital Acquired Infection Control Revenue Market Share by Application (2013-2018)
11.2 Hospital Acquired Infection Control Market Forecast by Application (2018-2023)
11.3 Air Revenue Growth (2013-2018)
11.4 Water Revenue Growth (2013-2018)
11.5 Physical Surfaces Revenue Growth (2013-2018)
11.6 Skin disinfectants Revenue Growth (2013-2018)
11.7 Sterilization Revenue Growth (2013-2018)
12 Global Hospital Acquired Infection Control Market Size Forecast (2018-2023)
12.1 Global Hospital Acquired Infection Control Market Size Forecast (2018-2023)
12.2 Global Hospital Acquired Infection Control Market Forecast by Regions (2018-2023)
12.3 North America Hospital Acquired Infection Control Revenue Market Forecast (2018-2023)
12.4 Europe Hospital Acquired Infection Control Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Hospital Acquired Infection Control Revenue Market Forecast (2018-2023)
12.6 South America Hospital Acquired Infection Control Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Hospital Acquired Infection Control Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Hospital Acquired Infection Control Picture
Table Product Specifications of Hospital Acquired Infection Control
Table Global Hospital Acquired Infection Control and
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
